Here you can learn how to add new statistical methods to your toolbox. These may not be neccessarily cutting edge methods, but approaches, that you are not yet aware about.
Interview with Josephine Wolfram What is Real World Evidence (RWE) about? What is the perspective of the FDA on real world data and evidence? The FDA guidance contains 3 big topics – what are these? RWE is one of the most hot topics in the industry and the way the FDA views this data source …
In this episode, we share out ideas and experiences, which mindset sets up statisticians for success. We cover topics around:
Interview with Lina Eliasson How does patient adherence affect the results of clinical trials?Are there ways to improve patient adherence to medication and treatments not only in clinical trials but also in real-life situations?What is the future of the value of clinical trials in terms of inclusive technological innovations? Clinical trials are designed to test …
Interview with Liz Thompson Why would a person working under the rules and purpose of statistics for 30 years want something more than what she has been an expert with for many years? Do you want something more out of your statistician background? What could statisticians offer outside of the field of statistics in healthcare? …
Stepping outside of our functions as statisticians with your career Read More »
Why should statisticians aim for becoming good leaders? How do you invest in yourself to become a good leader? How does perseverance change the path taken by a leader in the field of statistics? Gary Sullivan and I team up together to discuss the importance of leadership among statisticians. Understanding the basic factors of leadership …
Interview with Jenny Devenport Publications are part of the bigger communication plan which also covers PR, scientific dialog, promotion, training, and internal communications. Writing publications should follow an overall strategy for the compound or therapeutic area. They are necessary for further steps like having promotional material, HTA submissions, scientific/medical dialog, etc. They should not be …
Publications in launch and lifecycle – Insights you don’t want to miss! Read More »